The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$22.09

Today's change+0.37 +1.70%
Updated July 20 9:42 AM EDT. Delayed by at least 15 minutes.
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$22.09

Today's change+0.37 +1.70%
Updated July 20 9:42 AM EDT. Delayed by at least 15 minutes.

Valeant Pharmaceuticals International Inc up sharply

Valeant Pharmaceuticals International Inc is up sharply today, rallying $0.37 or 1.70% to $22.09. Over the last five days, shares have gained 0.32% and 13.46% year to date. Shares have underperformed the S&P TSX by 36.42% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward5.90×
  • Forward PEG0.76×
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$5.10
Updated July 20 9:42 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.33%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue2,1092,4032,4802,420
Total other revenue--------
Total revenue2,1092,4032,4802,420
Gross profit1,5131,7371,8221,762
Total cost of revenue596665658658
Total operating expense1,9622,2523,3432,340
Selling / general / administrative661665661672
Research & development9693101124
Depreciation / amortization635284807888
Interest expense (income), net operating--------
Unusual expense (income)-274531,11544
Other operating expenses, total1931-45
Operating income147150-86381
Interest income (expense), net non-operating-474-467-470-473
Gain (loss) on sale of assets--------
Other--------
Income before tax-295-360-1,332-377
Income after tax629-512-1,219-304
Income tax, total-924152-113-73
Net income628-515-1,218-302
Total adjustments to net income--------
Net income before extra. items628-515-1,218-302
Minority interest-1-312
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items628-515-1,218-302
Inc. avail. to common incl. extra. items628-515-1,218-302
Diluted net income627-515-1,218-302
Dilution adjustment-1----0
Diluted weighted average shares351350350345
Diluted EPS excluding extraordinary itemsvalue per share1.79-1.47-3.49-0.88
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.77-0.65-1.38-0.78